Advertisement

Journal of Proteins and Proteomics

, Volume 10, Issue 2, pp 109–120 | Cite as

A network pharmacology approach to investigate the pharmacological effect of curcumin and capsaicin targets in cancer angiogenesis by module-based PPI network analysis

  • Sharath Belenahalli Shekarappa
  • Shivananda Kandagalla
  • Manjunatha HanumanthappaEmail author
Original Article
  • 3 Downloads

Abstract

Curcumin and capsaicin play a vital role in anti-inflammatory and anti-cancer mechanism as they are used as therapeutic drugs/adjuvants. Our previous study including many reports explored strong inhibitory effect of curcumin and capsaicin on lipopolysaccharide-induced polymorph blood mononuclear cells (PBMCs) and cancer cells. Therefore, a systematic study was carried out to identify the potential protein targets of curcumin and capsaicin in cancer as well as angiogenesis through network pharmacology and molecular docking approaches. In the present investigation, we employed integrative prediction of cancer targets of curcumin and capsaicin through the ChEMBL and STITCH databases, followed by network construction, network topology, gene ontology, pathway enrichment and molecular docking studies. The gene ontology analysis made it possible to identify a library of possible cancer targets of curcumin (34 targets) and capsaicin (35 targets). Based on topological analysis, the unique target of curcumin and capsaicin was proposed by identifying essential bottleneck/hub node MAPK1. Further, PANTHER gene set analysis was used to distinguish the biologically enriched pathways in top identified gene clusters (MAPK1). To validate the identified target, high-throughput molecular docking was employed as both molecules curcumin and capsaicin along with standard ulixertinib were docked against MAPK1 to understand the binding interaction. The docking results of MAPK1 with curcumin (− 7.6 kcal/mol) has shown good inhibitory effect similar to that of standard control ulixertinib (− 8.1 kcal/mol) compared with capsaicin (− 6.0 kcal/mol). Based on the molecular interaction, MAPK1 identified through the network pharmacology approach could be a probable target of curcumin and capsaicin to prevent angiogenesis in cancer.

Keywords

Network pharmacology Drug–target interaction Curcumin Capsaicin Molecular docking 

Notes

Acknowledgements

The authors are thankful to the Registrar, Kuvempu University, Shankaraghatta-577 451 for providing facilities to complete this work.

Compliance with ethical standards

Conflict of interest

The authors have declared that there is no conflict of interest.

Supplementary material

42485_2019_12_MOESM1_ESM.xlsx (21 kb)
Supplementary material 1 (XLSX 20 kb)
42485_2019_12_MOESM2_ESM.xlsx (16 kb)
Supplementary material 2 (XLSX 16 kb)

References

  1. Assenov Y, Ramírez F, Schelhorn S-E, Lengauer T, Albrecht M (2008) Computing topological parameters of biological networks. Bioinformatics 24:282–284CrossRefGoogle Scholar
  2. Belenahalli Shekarappa S, Kandagalla S, Gollapalli P, BasavapattanaRudresh B, Hanumanthappa T, Hanumanthappa M (2017) Topology of protein–protein interaction network and edge reduction co-efficiency in VEGF signaling of breast cancer. Netw Model Anal Heal Inform Bioinform 6:17CrossRefGoogle Scholar
  3. Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y (2014) cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8:S11CrossRefGoogle Scholar
  4. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40:D1100–D1107CrossRefGoogle Scholar
  5. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV (2008) Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65:1631–1652CrossRefGoogle Scholar
  6. Huang D, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC, Lempicki RA (2007) The DAVID gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 8:R183CrossRefGoogle Scholar
  7. Kandagalla S, Sharath BS, Bharath BR, Hani U, Manjunatha H (2017) Molecular docking analysis of curcumin analogues against kinase domain of ALK5. Silico Pharmacol 5(1):15CrossRefGoogle Scholar
  8. Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27–30CrossRefGoogle Scholar
  9. Kempaiah RK, Manjunatha H, Srinivasan K (2005) Protective effect of dietary capsaicin on induced oxidation of low-density lipoprotein in rats. Mol Cell Biochem 275:7–13CrossRefGoogle Scholar
  10. Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269:199–225CrossRefGoogle Scholar
  11. Liu W, Wu A, Pellegrini M, Wang X (2015) Integrative analysis of human protein, function and disease networks. Sci Rep 5:14344CrossRefGoogle Scholar
  12. Manjunatha H, Srinivasan K (2006) Protective effect of dietary curcumin and capsaicin on induced oxidation of low-density lipoprotein, iron-induced hepatotoxicity and carrageenan-induced inflammation in experimental rats. FEBS J 273:4528–4537CrossRefGoogle Scholar
  13. Mi H, Poudel S, Muruganujan A, Casagrande JT, Thomas PD (2016) PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res 44:D336–D342CrossRefGoogle Scholar
  14. Oyagbemi AA, Saba AB, Azeez OI (2010) Capsaicin: a novel chemopreventive molecule and its underlying molecular mechanisms of action. Indian J Cancer 47:53–58CrossRefGoogle Scholar
  15. Pyun B-J, Choi S, Lee Y, Kim T-W, Min J-K, Kim Y, Kim B-D, Kim J-H, Kim T-Y, Kim Y-M, Kwon Y-G (2008) Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity. Cancer Res 68:227–235CrossRefGoogle Scholar
  16. Raman K (2010) Construction and analysis of protein–protein interaction networks. Autom. Exp. 2:2CrossRefGoogle Scholar
  17. Ran J, Li H, Fu J, Liu L, Xing Y, Li X, Shen H, Chen Y, Jiang X, Li Y, Li H (2013) Construction and analysis of the protein-protein interaction network related to essential hypertension. BMC Syst Biol 7:32CrossRefGoogle Scholar
  18. Rose PW, Prlić A, Bi C, Bluhm WF, Christie CH, Dutta S, Green RK, Goodsell DS, Westbrook JD, Woo J, Young J, Zardecki C, Berman HM, Bourne PE, Burley SK (2015) The RCSB Protein Data Bank: views of structural biology for basic and applied research and education. Nucleic Acids Res 43:D345–D356CrossRefGoogle Scholar
  19. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504CrossRefGoogle Scholar
  20. Sun PG, Gao L, Han S (2011) Prediction of human disease-related gene clusters by clustering analysis. Int. J. Biol. Sci. 7:61–73CrossRefGoogle Scholar
  21. Sung B, Prasad S, Yadav VR, Aggarwal BB (2012) Cancer cell signaling pathways targeted by spice-derived nutraceuticals. Nutr Cancer 64:173–197CrossRefGoogle Scholar
  22. Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, Kuhn M, Bork P, Jensen LJ, von Mering C (2015) STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res 43:D447–D452CrossRefGoogle Scholar
  23. Szklarczyk D, Santos A, von Mering C, Jensen LJ, Bork P, Kuhn M (2016) STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Res 44:D380–D384CrossRefGoogle Scholar
  24. Tang J, Aittokallio T (2014) Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles. Curr Pharm Des 20:23–36CrossRefGoogle Scholar
  25. Trott O, Olson AJ (2010) AutoDockVina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461Google Scholar
  26. vanAalten DMF, Bywater R, Findlay JBC, Hendlich M, Hooft RWW, Vriend G (1996) PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules. J Comput Aided Mol Des 10:255–262CrossRefGoogle Scholar
  27. Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH (2009) PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res 37:W623–W633CrossRefGoogle Scholar
  28. Xu X, Bi J, Ping L, Li P, Li F (2018) A network pharmacology approach to determine the synergetic mechanisms of herb couple for treating rheumatic arthritis. Drug Des Dev Ther 12:967–979CrossRefGoogle Scholar
  29. Zhang Y, Mao X, Guo Q, Lin N, Li S (2016) Network pharmacology-based approaches capture essence of Chinese herbal medicines. Chin Herb Med 8:107–116CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Sharath Belenahalli Shekarappa
    • 1
  • Shivananda Kandagalla
    • 1
  • Manjunatha Hanumanthappa
    • 1
    Email author
  1. 1.Department of PG Studies and Research in Biotechnology and BioinformaticsKuvempu UniversityShimogaIndia

Personalised recommendations